Back to GetFilings.com



 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q

x

 

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2004

OR

o

 

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission file number 1-10879


AMPHENOL CORPORATION

Delaware
(State of Incorporation)

 

22-2785165
(IRS Employer
Identification No.)

 

358 Hall Avenue
Wallingford, Connecticut 06492
203-265-8900


Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.   Yes x No o

Indicate by checkmark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).   Yes x No o

As of July 31, 2004, the total number of shares outstanding of Class A Common Stock was 87,918,660.

 




 

Amphenol Corporation

Index to Quarterly Report
on Form 10-Q

 

 

 

Page

Part I

 

Financial Information

 

 

Item 1.

 

Financial Statements:

 

 

 

 

Condensed Consolidated Balance Sheets at June 30, 2004 (unaudited) and December 31, 2003

 

3

 

 

Consolidated Statements of Income (unaudited) for the Three and Six Months Ended June 30, 2004 and 2003

 

4

 

 

Condensed Consolidated Statements of Cash Flow (unaudited) for the Six Months Ended June 30, 2004 and 2003

 

5

 

 

Notes to Condensed Consolidated Financial Statements

 

6

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations 

 

10

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk

 

13

Item 4.

 

Controls and Procedures

 

14

Part II

 

Other Information

 

 

Item 1.

 

Legal Proceedings

 

15

Item 2.

 

Changes in Securities

 

15

Item 3.

 

Defaults upon Senior Securities

 

15

Item 4.

 

Submission of Matters to a Vote of Security-Holders

 

15

Item 5.

 

Exhibits and Reports on Form 8-K

 

16

Signatures

 

17

Exhibit Index

 

18

 

2




PART I — FINANCIAL INFORMATION

Item 1. Financial Statements

AMPHENOL CORPORATION
CONDENSED CONSOLIDATED BALANCE SHEETS
(dollars in thousands)

 

 

June 30,
2004

 

December 31,
2003

 

 

 

(Unaudited)

 

 

 

ASSETS

 

 

 

 

 

Current Assets:

 

 

 

 

 

Cash and short term cash investments

 

$

18,627

 

$

23,533

 

Accounts receivable, less allowance for doubtful accounts of $10,303 and $9,244, respectively

 

206,248

 

172,488

 

Inventories

 

230,266

 

221,385

 

Prepaid expenses and other assets

 

34,644

 

33,943

 

Total current assets

 

489,785

 

451,349

 

Land and depreciable assets, less accumulated depreciation of $322,773 and $327,469, respectively

 

175,559

 

178,266

 

Deferred debt issuance costs

 

6,303

 

7,014

 

Goodwill

 

518,498

 

516,335

 

Deferred taxes and other assets

 

22,924

 

28,420

 

 

 

$

1,213,069

 

$

1,181,384

 

LIABILITIES AND SHAREHOLDERS’ EQUITY

 

 

 

 

 

Current Liabilities:

 

 

 

 

 

Accounts payable

 

$

126,797

 

$

116,835

 

Accrued interest

 

2,416

 

2,939

 

Accrued salaries, wages and employee benefits

 

35,181

 

31,091

 

Other accrued expenses

 

58,554

 

56,098

 

Current portion of long-term debt

 

11,230

 

10,679

 

Total current liabilities

 

234,178

 

217,642

 

Long-term debt

 

465,438

 

532,280

 

Accrued pension and post employment benefit obligations

 

102,672

 

100,326

 

Other liabilities

 

10,886

 

7,730

 

Shareholders’ Equity:

 

 

 

 

 

Common stock

 

88

 

88

 

Additional paid-in capital (deficit)

 

(221,132

)

(238,168

)

Accumulated earnings

 

702,455

 

626,430

 

Accumulated other comprehensive loss

 

(65,342

)

(64,944

)

Treasury stock, at cost

 

(16,174

)

 

Total shareholders’ equity

 

399,895

 

323,406

 

 

 

$

1,213,069

 

$

1,181,384

 

 

See accompanying notes to condensed consolidated financial statements.

3




AMPHENOL CORPORATION
 CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
(dollars in thousands, except per share data)

 

 

Three months ended
June 30,

 

Six months ended
June 30,

 

 

 

2004

 

2003

 

2004

 

2003

 

Net sales

 

$

387,119

 

$

304,893

 

$

742,380

 

$

582,667

 

Costs and expenses:

 

 

 

 

 

 

 

 

 

Cost of sales, excluding depreciation and amortization

 

254,031

 

203,200

 

487,261

 

385,853

 

Depreciation and amortization expense

 

9,733

 

9,566

 

19,166

 

18,374

 

Selling, general and administrative expense

 

54,301

 

42,868

 

105,616

 

84,010

 

Operating income

 

69,054

 

49,259

 

130,337

 

94,430

 

Interest expense

 

(5,673

)

(7,694

)

(11,428

)

(15,818

)

Other expenses, net

 

(2,219

)

(1,685

)

(3,719

)

(3,409

)

Expense for early extinguishment of debt

 

 

(10,367

)

 

(10,367

)

Income before income taxes

 

61,162

 

29,513

 

115,190

 

64,836

 

Provision for income taxes

 

(20,795

)

(10,034

)

(39,165

)

(22,044

)

Net income

 

$

40,367